Adachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal

Similar documents
Peggy Leslie-Smith, RN

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series

RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS

Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia

The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers

TB Intensive San Antonio, Texas November 11 14, 2014

The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-c release assay

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

TB Intensive Houston, Texas October 15-17, 2013

Prevalence of Latent Tuberculosis Infection among Health Care Workers in South Korea: A Multicenter Study

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection

Approaches to LTBI Diagnosis

Diagnosis Latent Tuberculosis. Disclosures. Case

Analysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy

TB Prevention Who and How to Screen

Screening of HIV-Infected Patients with IGRAs for LTBI. Background. Tuberculosis is the most prevalent in the world.

Investigation of false-positive results by the QuantiFERON-TB Gold In-Tube assay

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

The Role of the Interferon Gamma Release Assay in Assessing Recent Tuberculosis Transmission in a Hospital Incident

Within-Subject Variability of Mycobacterium tuberculosis-specific Gamma Interferon Responses in German Health Care Workers

2017/2018 Annual Volunteer Tuberculosis Notice

Richard N. van Zyl-Smit 1, Rannakoe J. Lehloenya 1,2, Richard Meldau 1, Keertan Dheda 1,3,4. Introduction

TB Intensive Tyler, Texas December 2-4, 2008

Student Health Requirements Master of Arts, Biomedical Sciences Program

CUSOM Student Health Immunization Requirements

QFT. 457 QuantiFERON -TB 2nd Generation QFT m 2 キーワーズ QFT QFT QFT QFT BCG. Kekkaku Vol. 85, No. 6: 547_552, 2010

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the

Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -

Technical Bulletin No. 172

Predictive Value of interferon-gamma release assays for incident active TB disease: A systematic review

Thorax Online First, published on December 8, 2009 as /thx

Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients*

RISK FACTORS FOR LATENT TUBERCULOSIS INFECTION AMONG HEALTH-CARE WORKERS IN NORTHEASTERN THAILAND

Author's response to reviews

QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients

These recommendations will remain in effect until the national shortage of PPD solution has abated.

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Identifying TB co-infection : new approaches?

Validity of interferon-c-release assays for the diagnosis of latent tuberculosis in haemodialysis patients

QuantiFERON-TB Gold Plus

Conflict of Interest Disclosures:

Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Didactic Series. Latent TB Infection in HIV Infection

Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers

Mædica - a Journal of Clinical Medicine

Interferon-gamma release assay for treatment monitoring of active tuberculosis

Self-Study Modules on Tuberculosis

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Factors influencing tuberculosis screening in healthcare workers in Portugal

Coordinating with Public Health on Tuberculosis Testing & Treatment

LATENT TUBERCULOSIS. Robert F. Tyree, MD

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

How to interpret the new QuantiFERON- TB Gold Plus test (QFT-Plus)

Didactic Series. Latent TB Infection in HIV Infection

Performance of QuantiFERON-TB Gold and Tuberculin Skin Test Relative to Subjects Risk of Exposure to Tuberculosis

Gerd Gran 1, Jörg Aßmus 2 and Anne Ma Dyrhol-Riise 3,4,5*

An evaluation of the QuantiFERONÂ Gold tuberculosis-screening test for employees at the Portland Veterans Affairs Medical Center

Interpretation of TST & IGRA results. Objectives

Tuberculosis: Where Are We Now?

Is the QuantiFERON-TB Blood Assay a Good Replacement for the Tuberculin Skin Test in Tuberculosis Screening? A Pilot Study at Berkshire Medical Center

Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review

Northwestern Polytechnic University

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment

Persistently Retained Interferon-Gamma Responsiveness in Individuals with a History of Pulmonary Tuberculosis

(a) Infection control program. The facility must establish an infection control program under which it--

Nguyen Van Hung (NTP, Viet Nam)

Clinical Study Levels of Interferon-Gamma Increase after Treatment for Latent Tuberculosis Infection in a High-Transmission Setting

Risk of tuberculosis among air passengers estimated by interferon gamma release assay: survey of contact investigations, Japan, 2012 to 2015

T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS

The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over?

TB Screening Guidelines for Transitional Care Unit

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

Report on WHO Policy Statements

Update on IGRA Predictive Value

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening

COFM Immunization Policy 2016

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Albert Nienhaus 1,2* and José Torres Costa 3

Incidence of occupational latent tuberculosis infection in South African healthcare workers

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

ERJ Express. Published on July 30, 2013 as doi: / Disease Prevention and Control (ECDC), Stockholm, Sweden

Dimitrios Vassilopoulos,* Stamatoula Tsikrika, Chrisoula Hatzara, Varvara Podia, Anna Kandili, Nikolaos Stamoulis, and Emilia Hadziyannis

Journal of Infectious Diseases Advance Access published August 2, 2013

Proposed Regs.pdf

COMPARISON OF TWO INTERFERON-G ASSAYS AND

Variation in T-SPOT.TB spot interpretation between independent observers of different laboratories

Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Screening travellers to high-endemic countries for infection with Mycobacterium tuberculosis using interferon gamma release assay; a prospective study

Transcription:

Adachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal RESEARCH Open Access Tuberculosis examination using whole blood interferon-gamma release assay among health care workers in a Japanese hospital without tuberculosis-specific wards Eisuke Adachi 1*, Mika Kogayu 2, Takeshi Fujii 1, Hiroshi Mae 3, Shoichi Shimizu 1, Yuichi Iwai 3, Hiroko Shibata 4, Masato Suzuki 4, Kohzoh Imai 5 and Tomohiko Koibuchi 1 Abstract Occupational latent tuberculosis infection (LTBI) among health care workers (HCWs) is an important public health issue. The objective of this study is to assess prevalence and risk factors of LTBI among Japanese HCWs by Quantiferon-TB Gold in Tube (QFT-GIT) and the structured questionnaire. This is a cross-sectional study involving HCWs from a hospital without tuberculosis-specific wards, receiving QFT-GIT for LTBI screening. We reviewed medical records of HCWs and questioned HCWs about exposure to M. tuberculosis and employment length in health care industries. 165 HCWs, approximately 80% of the total hospital staff, were enrolled in this study.18 out of 165 subjects had positive results, suggesting LTBI prevalence rate of 11%. Multiple regression analysis revealed a significant association between the positive or intermediate QFT-GIT results and history of contact investigation for tuberculosis. QFT-GIT positivity rate among HCWs is higher than among general population in Japan. Keywords: Latent tuberculosis infection; Quantiferon-TB gold in tube; Latent tuberculosis infection baseline screening; Health care workers Background Occupational latent tuberculosis infection (LTBI) among health care workers (HCWs) is an important public health issue. World Health Organization (WHO) estimate of tuberculosis incidence of Japan in 2011 was 20 per 100,000 population per year. The Tuberculosis Surveillance Center of The research institute of Tuberculosis, Japan Anti-tuberculosis Association reported the incidence of tuberculosis of Japan was 18.2 in 2010 and 17.7 in 2011 (Rates per 100,000) and had continued to decline. However, approximately 80% of nurses with tuberculosis were speculated to be infected by nosocomial infection in Japan (Ohmori et al. 2007). The screening for LTBI by means of the tuberculin skin test (TST) or whole blood interferon-gamma release assays (IGRAs) and the * Correspondence: e-adachi@ims.u-tokyo.ac.jp 1 Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan Full list of author information is available at the end of the article administration of chemoprophylaxsis have been shown to be effective for prevention to develop active tuberculosis (Ringshausen et al. 2012; Pai et al. 2004). In Japan, TST use is limited for screening of LTBI, because most Japanese residents have received bacille Calmette-Guérin (BCG) vaccination on multiple occasions. Accordingly, The Japanese Society of Tuberculosis recommend the Quantiferon -TB Gold (QFT-G) test for the screening of Mycobacterium tuberculosis (M. tuberculosis) infection for HCWs or health care students (Hotta et al. 2007). Most of the previous studies described the prevalence of LTBI among Japanese HCWs were performed in tuberculosis referral hospitals. The objective of this studyistoassessprevalenceandriskfactorsofltbi among Japanese HCWs by Quantiferon-TB Gold in Tube (QFT-GIT), a new version of QFT-G, and the structured questionnaire in a hospital without tuberculosis-specific wards. 2013 Adachi et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Adachi et al. SpringerPlus 2013, 2:440 Page 2 of 5 Methods Setting and design This is a cross-sectional study involving HCWs at the hospital affiliated with the Institute of Medical Science, the University of Tokyo (IMSUT hospital), receiving QFT-GIT for LTBI screening between November 2011 and July 2012. IMSUT Hospital has 135 beds and four negative pressure isolation rooms for patients diagnosed with active tuberculosis accidentally. The hospital is not a tuberculosis referral hospital and has no tuberculosisspecific wards. There were three active tuberculosis patients admitted in the IMSUT hospital in 2007. This is the highest number of annul admission of active tuberculosis cases in the hospital. We reviewed medical records of HCWs and questioned HCWs about exposure to M. tuberculosis and employment length in health care industries. We utilized the questionnaire consisting of the following questions: age, job category, history of contact investigation for tuberculosis, history of living with families who developed active tuberculosis, past history of active/latent tuberculosis infection, length of working in health care industries (general hospitals, tuberculosis referral hospitals, clinics, nursing home), history of working in tuberculosis ward/out patient department (OPD). Eligible subjects had been working as HCWs for more than 6 months and never had received IGRAs for LTBI screening. We excluded the HCWs with history of active tuberculosis. Written informed consent was obtained from subjects before completing the study questionnaire. This study was approved by the Research Ethics Committee, Institutional Review Board of IMSUT (accession number: 24-6, 24-32). Quantiferon -TB Gold in Tube Blood samples for QFT-GIT tests (Cellestis Limited. Australia) were collected at our hospital and QFT-GIT tests were performed at laboratories in the clinical laboratory testing industry (SRL Inc. Japan). Interferongamma (IFN-γ) responses to antigens that are at least 0.35 IU/mL greater than the nil control value are considered M. tuberculosis infection ( positive ). We also evaluated a prevalence using the value of 0.10 IU/mL as an alternative cut-off ( intermediate ) astheguideline of committees for the preventions of The Japanese Society of Tuberculosis. If the response is less than a cut-off value and their response to the mitogen positive control is greater than 0.5 IU/mL, the test result is considered negative. Statistical analysis Comparisons of proportions were analyzed by the chisquare test or the Fisher exact test and a linear trend in proportions of ordered multiple groups were analyzed by Mantel-extension test. Multiple logistic regression analysis was performed (using JMP 9 software; SAS Institute Inc.) with the following independent variables: male/female, age groups, job category, history of contact investigation for tuberculosis, history of living with families who developed active tuberculosis and history of working in tuberculosis ward or OPD for more than 2months. Results 165 HCWs, approximately 80% of the total hospital staff, were enrolled in this study. All subjects were Japanese. Table 1 shows the QFT-GIT positivity rates and characteristics of HCWs. 18 out of 165 subjects (10.9%) had positive results (0.35 IU/mL, cut-off). None of them manifested signs of active tuberculosis by their chest radiograph. 38 subjects (23%) had the value of QFT-GIT showed greater than 0.10 IU/mL. Notably, among HCWs aged 30-39 years, 14% of subjects (10/70) had positive QFT-GIT result. Table 2 shows the results of univariate analysis of tuberculosis infection risk factors. Univariate analysis revealed a significant association between the positive or intermediate QFT-GIT results and history of contact investigation for tuberculosis (odds ratio (OR) 3.4, 95% confidence interval (CI) 1.1 to 10.0). Neither age nor length of working in health care industries was associated with results of QFT-GIT among all HCWs. Among nurses and doctors aged 20-49 years, the percentage of HCWs with positive QFT-GIT results increased for each decade of age (odds ratios relative to persons aged 20-29 years, 2.5 Table 1 Characteristics of HCWs and Quantiferon TB-Gold in tube positivity rate Total (number) 165 Gender male 60 (36.4%) female 105 (63.4%) Age (years, (IQR)) 38 a (32-46) Job category nurse 72 (43.6%) doctor 53 (32.1%) laboratory* 12 (7.27%) pharmacist 12 (7.27%) other** 16 (9.70%) Length of working in health care industries (years, (IQR)) 13 a (7-18) History of contact investigation for TB 25 (15.2%) History of living with families who developed active TB 7 (4.24%) History of working in TB ward/opd 14 (8.48%) QFT-GIT positivity (%) Cut off: 0.35 IU/mL 18 (10.9%) Cut off: 0.10 IU/mL 38 (23.0%) Note. IQR, interquartile range; TB, tuberculosis; OPD, outpatient department; QFT-GIT, Quantiferon TB-Gold in tube; * Laboratory technician ** radiography technicians, nutritionist, clerical, nursing assistants and social workers; a median.

Adachi et al. SpringerPlus 2013, 2:440 Page 3 of 5 Table 2 Association between results of Quantiferon TB-Gold in tube and risk factors for tuberculosis infection No of subjects No of subjects Cut off: 0.35 IU/mL Cut off: 0.1 IU/mL 0.35 0.35 OR(95% CI) 0.1 0.1 OR(95% CI) Male 10 50 2.4 (0.90-6.5, P = 0.12 b ) 15 45 1.2 (0.56-2.5, P = 0.7 b ) Female 8 97 23 82 Job category Nurse 6 66 1.0 a P = 0.18 b 14 58 1.0 a P = 0.69 b Doctor 5 48 1.1 12 41 1.2 Laboratory* 3 9 3.7 4 8 2.1 Pharmacist 3 9 3.7 3 9 1.4 other** 1 15 0.73 5 11 1.9 age 20-29 2 24 1.0 a P = 0.76 b 6 20 1.0 a P = 0.63 b 30-39 10 60 2.0 17 53 1.1 40-49 4 38 1.3 7 35 0.67 50-2 25 0.96 8 19 1.4 Length of working in health care industries 0-4 3 25 1.0 a P = 0.21 b 6 22 1.0 a P = 0.87 b 5-9 1 30 0.28 5 26 0.71 10-14 6 37 1.4 11 32 1.3 15-19 6 23 2.3 7 22 1.2 20-2 32 0.52 9 25 1.3 History of contact investigation for TB Yes 6 19 3.4 (1.1-10.0, P = 0.034 b ) 12 13 4.0 (1.66-9.9, P = 0.003 b ) No 12 128 26 114 History of living with families who developed active TB Yes 2 5 3.6 (0.64-20, P = 0.17 b ) 3 4 2.6 (0.56-12.0, P = 0.20 b ) No 16 142 35 123 History of working in TB ward/opd Yes 1 13 0.61 (0.075-4.9, P = 1.0 b ) 3 11 0.90 (0.24-3.4, P = 1.0 b ) No 17 134 35 116 Note. OR, odds ratio; CI, confidence interval; TB, tuberculosis; OPD, outpatient department; * Laboratory technician ** radiography technicians, nutritionist, clerical, nursing assistants and social workers; a reference; b Fisher Exact test. (30-39 years), 2.9 (40-49 years)), but it did not reach statistical significance. Multiple logistic regression analysis to risk factors revealed that positive QFT-GIT result was significantly associated with male/female, the history of contact investigation for tuberculosis (Table 3). Discussion The utility of IGRAs in countries where BCG vaccine is widely used is supported by many studies (Pai et al. 2004). Harada et al. reported that a prevalence of LTBI among HCWs in a Japanese tuberculosis referral hospital was 9.9% by means of QFT-G (Harada et al. 2006). However, QFT-GIT, a new version of QFT-G, has higher sensitivity than QFT-G with high specificity for M. tuberculosis infection and is the currently recommended method for screening of LTBI in HCWs (Harada et al. 2008). Mori et al. reported that the QFT-G positivity rate of general population was 7.1% (40 69 years); it increased with age from 3.1% for the 40 49 years age group to 9.8% for those aged 60 69 (Mori et al. 2007). We conducted here a cross-sectional study for HCWs receiving QFT-GIT. It showed the prevalence of LTBI to be 11%, which is remarkably higher than that among the general population (Mori et al. 2007). The QFT-GIT positivity rate in our study is consistent with the previous report from a tuberculosis referral hospital in Japan (Harada et al. 2006). We found that the prevalence of LTBI among HCWs in general hospitals without tubercu-

Adachi et al. SpringerPlus 2013, 2:440 Page 4 of 5 Table 3 Multivariate analysis of association between results of Quantiferon TB-Gold in tube and risk factors for tuberculosis infection Cut off: 0.35 IU/mL Cut off: 0.1 IU/mL OR P OR P Male/ female 8.0 0.011 1.3 0.41 Job category Nurse 1.0 a 1.0 a Doctor 0.34 0.30 1.4 0.66 Laboratory technician 6.5 0.092 2.6 0.26 Pharmacist 4.9 0.096 1.7 0.51 Other* 1.5 0.76 2.9 0.13 Age 20-29 1.0 a 1.0 a 30-39 2.0 0.42 0.90 0.87 40-49 0.92 0.93 0.33 0.12 50-0.23 0.26 0.83 0.78 History of contact investigation for TB 6.4 0.0077 4.7 0.0017 History of living with familes 6.0 0.11 3.3 0.24 who developed active TB History of working in TB ward/opd 0.62 0.70 0.67 0.62 Note. OR, odds ratio; TB, tuberculosis; OPD, outpatient department * radiography technicians, nutritionist, clerical, nursing assistants and social workers; a reference. losis wards and among HCWs in tuberculosis referral hospitals is similar. The report from the tuberculosis referral hospital also described that the positive QFT-G results were closely associated with age and with a history of working in a tuberculosis ward or an OPD of a tuberculosis clinic (Harada et al. 2006). In our study, positive QFT-GIT results were associated with the history of contact investigation for tuberculosis, that is suggestiveofthehistoryofexposuretom. tuberculosis. Of note, a high proportion of HCWs with positive/ intermediate QFT-GIT results was laboratory technicians, which was consistent with the previous report (Harada et al. 2006). These suggest laboratory technicians are likely to be exposed to infectious agents in handling patients samples, such as sputum. There were no laboratory technicians with the history of contact investigation for tuberculosis in our study. We would like to offer that laboratory technicians should be included as subjects in performing contact investigation. Our study has several limitations, including the small sample size and a single-center study. Diagnosis of LTBI by means of single QFT-GIT test remains controversial in accuracy and reliability, because the specific IFN-γ response may wane considerably with time after infection and a substantial technical variability exists (Ringshausen et al. 2012; Mori et al. 2007; Pai and O Brien 2007). Mori et al. demonstrated that the probability of infection increases almost exponentially after 30 years of age (Mori 2000). The fact that age was not associated with results of QFT-GIT in our study may be due to the samplesize bias. Our study is first to offer QFT-GIT positivity rate among Japanese HCWs in a hospital without tuberculosisspecific wards. To establish the evaluation of the LTBI by means of QFT-GIT test, several large, multi-center studies might be warranted. Conclusions QFT-GIT positivity rate among HCWs is higher than among general population in Japan. This study showed the prevalence of LTBI among Japanese HCWs was 11%. Occupational LTBI among HCWs is an important public health issue. Competing interests The authors declare that they have no competing interests Authors contributions EA and MK designed the project and carried out research. EA drafted manuscript. TF, KI and TK contributed to project design and revised the drafted manuscript. HM, SS, YI, HS and MS contributed to data collections. All authors read and approved the final manuscript. Acknowledgment The authors thank Kei Ouchi, MD, for his comments on drafts of the manuscript. Author details 1 Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. 2 Department of Nursing, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. 3 Department of Pharmacy, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. 4 Department of Laboratory Medicine, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. 5 Director, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Received: 13 June 2013 Accepted: 2 September 2013 Published: 5 September 2013 References Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T (2006) Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27:442 448 Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, Horiba M, Mitarai S, Yonemaru M, Ogata H, Ariga H, Kurashima A, Wada A, Takamori M, Yamagishi F, Suzuki K, Mori T, Ishikawa N (2008) Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 56:348 353 Hotta K, Ogura T, Nishii K, Kodani T, Onishi M, Shimizu Y, Kanehiro A, Kiura K, Tanimoto M, Tobe K (2007) Whole blood interferon-gamma assay for baseline tuberculosis screening among Japanese healthcare students. PLoS One 2:e803 Mori T (2000) Recent trends in tuberculosis, Japan. Emerg Infect Dis 6(6):566 568 Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T (2007) Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis 11:1021 1025

Adachi et al. SpringerPlus 2013, 2:440 Page 5 of 5 Ohmori M, Hoshino H, Yamauchi Y, Uchimura K (2007) Current epidemiological situation of tuberculosis in the workplace: considering the risk of tuberculosis among nurses. Kekkaku 82:85 93 Pai M, O Brien R (2007) Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 4:e208 Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761 776 Ringshausen FC, Schablon A, Nienhaus A (2012) Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 7:6 doi:10.1186/2193-1801-2-440 Cite this article as: Adachi et al.: Tuberculosis examination using whole blood interferon-gamma release assay among health care workers in a Japanese hospital without tuberculosis-specific wards. SpringerPlus 2013 2:440. Submit your manuscript to a journal and benefit from: 7 Convenient online submission 7 Rigorous peer review 7 Immediate publication on acceptance 7 Open access: articles freely available online 7 High visibility within the field 7 Retaining the copyright to your article Submit your next manuscript at 7 springeropen.com